SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurocrine Biosciences (NBIX)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
1834 74 0 NBIX
Emcee:  Billy Dunn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
984Tuesday August 13, 7:32 am Eastern Time Press Release SOURCE: Neurocrine Biosciescaram(o)uche-8/13/2002
983Thanks for posting that!! Saw Ted David rip into the analyst from Sterling thisHawkmoon-8/9/2002
982I cannot fathom it. Simply a revolting human being. alas, the dark side of gremopgcw-8/8/2002
981>> By GEETA ANAND and RANDALL SMITH << Oh, geeeeeeze, she's on scaram(o)uche-8/8/2002
980<i>His own incident "put a damper on my phone conversations with doctscaram(o)uche-8/8/2002
979Nature 418, 650 - 654 (2002) Gut hormone PYY3-36 physiologically inhibits fooscaram(o)uche-8/8/2002
978>> The Vollum Institute is the academic institution working with NBIX in tscaram(o)uche-8/8/2002
977Biotech Analysts Strive to Peek Inside Clinical Tests of Drugs By GEETA ANAND amopgcw-8/8/2002
976Since she's calling for roughly a 15% decline from the 7/29 close, I wonder tom pope-7/31/2002
97512-20% net royalties??? No wonder their recommendation is "neutral". keokalani'nui-7/31/2002
974SSB Part II: With respect to safety, overall, the drug was well tolerated. Themopgcw-7/30/2002
973SSB latest report: Neurocrine Biosciences (NBIX) NBIX: Reports Second Quarter Fmopgcw-7/30/2002
972Drool. (eom)scaram(o)uche-7/30/2002
971[CRF(1) binding study] Neuropsychopharmacology 2002 Aug;27(2):194-202 Related Akeokalani'nui-7/30/2002
970[GnRH receptor binding--study/letter] Bioorg Med Chem Lett 2002 Aug 19;12(16):2keokalani'nui-7/30/2002
969Peter, Ice, nice finds (work, Peter, meeting, Ice)! Thanks! I'd consider tscaram(o)uche-7/29/2002
968Peter That is interesting (of course). The Vollum Institute is the academic insIcebrg-7/29/2002
967Fen-phen works via melanocortin: <i>Activation of Central Melanocortin PaBiomaven-7/29/2002
966>> Digital Symbol Substitution Test << The speed required to switchscaram(o)uche-7/12/2002
965"Number of awakenings after sleep onset (Nasso)" = 7+ ???? Does thankeokalani'nui-7/12/2002
964From SSB report on Indiplon P2 results: (sorry for late posting) Neurocrine Biomopgcw-7/12/2002
963Diabetes 2002 Jul;51(7):2126-34 Immunological Characterization and TherapeuticMiljenko Zuanic-6/30/2002
962Harry, I apologize if I am going on your nerve. I understand that I am asking fMiljenko Zuanic-6/27/2002
961Wilder: Over the past six months, I've had most of the hubris pretty much exNeuroInvestment-6/26/2002
960>>'Land with both feet'...I guess I am going to have to watch mysekeokalani'nui-6/26/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News